# Wolfspeed, Inc.: financial statements, quarterly

WOLF · NYSE · CIK 895419 · [Technology](/sectors/technology.md) · fiscal year ends Jun 29

Pages: [Overview](/companies/wolf.md) · [Financials](/companies/wolf/financials.md) · [Filings](/companies/wolf/filings.md) · [Insiders](/companies/wolf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wolf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [197](/filings/0000895419-24-000093.md) | [208](/filings/0000895419-25-000018.md) | [201](/filings/0000895419-25-000071.md) | [201 d](/filings/0000895419-26-000054.md) | [195](/filings/0000895419-25-000132.md) | [181](/filings/0000895419-26-000016.md) | [185](/filings/0000895419-26-000030.md) | [197 d](/filings/0000895419-26-000054.md) | [197](/filings/0000895419-25-000132.md) | [169](/filings/0000895419-26-000016.md) | [150](/filings/0000895419-26-000030.md) | [150 d](/filings/0000895419-26-000054.md) |
| Cost of revenue | $m | [173](/filings/0000895419-24-000093.md) | [181](/filings/0000895419-25-000018.md) | [178](/filings/0000895419-25-000071.md) | [198 d](/filings/0000895419-26-000054.md) | [231](/filings/0000895419-25-000132.md) | [218](/filings/0000895419-26-000016.md) | [208](/filings/0000895419-26-000030.md) | [223 d](/filings/0000895419-26-000054.md) | [274](/filings/0000895419-25-000132.md) | [247](/filings/0000895419-26-000016.md) | [190](/filings/0000895419-26-000030.md) | [186 d](/filings/0000895419-26-000054.md) |
| Gross profit | $m | [24.7](/filings/0000895419-24-000093.md) | [27.8](/filings/0000895419-25-000018.md) | [22.5](/filings/0000895419-25-000071.md) | [2.4 d](/filings/0000895419-26-000054.md) | [(36.2)](/filings/0000895419-25-000132.md) | [(37.2)](/filings/0000895419-26-000016.md) | [(22.5)](/filings/0000895419-26-000030.md) | [(25.7) d](/filings/0000895419-26-000054.md) | [(77.1)](/filings/0000895419-25-000132.md) | [(78.3)](/filings/0000895419-26-000016.md) | [(40.0)](/filings/0000895419-26-000030.md) | [(36.7) d](/filings/0000895419-26-000054.md) |
| Research and development | $m | [44.1](/filings/0000895419-24-000093.md) | [45.3](/filings/0000895419-25-000018.md) | [52.5](/filings/0000895419-25-000071.md) | [60.0 d](/filings/0000895419-26-000054.md) | [50.9](/filings/0000895419-25-000132.md) | [44.4](/filings/0000895419-26-000016.md) | [42.2](/filings/0000895419-26-000030.md) | [37.6 d](/filings/0000895419-26-000054.md) | [31.7](/filings/0000895419-25-000132.md) | [24.9](/filings/0000895419-26-000016.md) | [27.2](/filings/0000895419-26-000030.md) | [27.9 d](/filings/0000895419-26-000054.md) |
| Selling, general and administrative | $m | [64.1](/filings/0000895419-24-000093.md) | [64.9](/filings/0000895419-25-000018.md) | [55.8](/filings/0000895419-25-000071.md) | [61.6 d](/filings/0000895419-26-000054.md) | [62.2](/filings/0000895419-25-000132.md) | [51.1](/filings/0000895419-26-000016.md) | [41.1](/filings/0000895419-26-000030.md) | [36.1 d](/filings/0000895419-26-000054.md) | [37.9](/filings/0000895419-25-000132.md) | [29.4](/filings/0000895419-26-000016.md) | [37.0](/filings/0000895419-26-000030.md) | [37.3 d](/filings/0000895419-26-000054.md) |
| Operating income | $m | [(94.9)](/filings/0000895419-24-000093.md) | [(98.1)](/filings/0000895419-25-000018.md) | [(106)](/filings/0000895419-25-000071.md) | [(146) d](/filings/0000895419-26-000054.md) | [(230)](/filings/0000895419-25-000132.md) | [(323)](/filings/0000895419-26-000016.md) | [(195)](/filings/0000895419-26-000030.md) | [(582) d](/filings/0000895419-26-000054.md) | [(161)](/filings/0000895419-25-000132.md) | [(158)](/filings/0000895419-26-000016.md) | [(114)](/filings/0000895419-26-000030.md) | [(115) d](/filings/0000895419-26-000054.md) |
| Interest expense | $m | [61.7](/filings/0000895419-23-000135.md) | [64.3](/filings/0000895419-24-000012.md) | [59.5](/filings/0000895419-24-000038.md) | [60.8 d](/filings/0000895419-26-000054.md) | [64.5](/filings/0000895419-25-000132.md) | [80.5](/filings/0000895419-26-000016.md) | [85.4](/filings/0000895419-26-000030.md) | [84.8 d](/filings/0000895419-26-000054.md) | [0.7](/filings/0000895419-25-000132.md) | [58.0](/filings/0000895419-26-000016.md) | [52.1](/filings/0000895419-26-000030.md) | [39.8 d](/filings/0000895419-26-000054.md) |
| Income tax | $m | [0.2](/filings/0000895419-24-000093.md) | [0.3](/filings/0000895419-25-000018.md) | [0.1](/filings/0000895419-25-000071.md) | [0.5 d](/filings/0000895419-26-000054.md) | [0.4](/filings/0000895419-25-000132.md) | [(0.1)](/filings/0000895419-26-000016.md) | [0.1](/filings/0000895419-26-000030.md) | [(10.1) d](/filings/0000895419-26-000054.md) | [0.1](/filings/0000895419-25-000132.md) | [1.2](/filings/0000895419-26-000016.md) | [(0.3)](/filings/0000895419-26-000030.md) | [0.5 d](/filings/0000895419-26-000054.md) |
| Net income | $m | [(396)](/filings/0000895419-25-000071.md) | [(145)](/filings/0000895419-25-000071.md) | [(149)](/filings/0000895419-25-000071.md) | [(175) d](/filings/0000895419-26-000054.md) | [(282)](/filings/0000895419-26-000030.md) | [(372)](/filings/0000895419-26-000030.md) | [(286)](/filings/0000895419-26-000030.md) | [(669) d](/filings/0000895419-26-000054.md) | [(644)](/filings/0000895419-26-000030.md) | [(151)](/filings/0000895419-26-000030.md) | [(120)](/filings/0000895419-26-000030.md) | [(145) d](/filings/0000895419-26-000054.md) |
| Diluted EPS | $ per share | [(3.16)](/filings/0000895419-24-000093.md) | [(1.15)](/filings/0000895419-25-000018.md) | [(1.18)](/filings/0000895419-25-000071.md) | not reported | [(2.23)](/filings/0000895419-25-000132.md) | [(2.88)](/filings/0000895419-26-000016.md) | [(1.86)](/filings/0000895419-26-000030.md) | not reported | [(4.12)](/filings/0000895419-25-000132.md) | [(5.78)](/filings/0000895419-26-000016.md) | [(3.05)](/filings/0000895419-26-000030.md) | not reported |
| Basic EPS | $ per share | [(3.16)](/filings/0000895419-24-000093.md) | [(1.15)](/filings/0000895419-25-000018.md) | [(1.18)](/filings/0000895419-25-000071.md) | not reported | [(2.23)](/filings/0000895419-25-000132.md) | [(2.88)](/filings/0000895419-26-000016.md) | [(1.86)](/filings/0000895419-26-000030.md) | not reported | [(4.12)](/filings/0000895419-25-000132.md) | [(5.78)](/filings/0000895419-26-000016.md) | [(3.05)](/filings/0000895419-26-000030.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) | FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,762](/filings/0000895419-23-000135.md) | [904](/filings/0000895419-24-000012.md) | [1,142](/filings/0000895419-24-000038.md) | [1,046](/filings/0000895419-25-000110.md) | [726](/filings/0000895419-24-000093.md) | [614](/filings/0000895419-25-000018.md) | [730](/filings/0000895419-25-000071.md) | [467](/filings/0000895419-26-000054.md) | [572](/filings/0000895419-25-000132.md) | [1,029](/filings/0000895419-26-000016.md) | [695](/filings/0000895419-26-000030.md) | [576](/filings/0000895419-26-000054.md) |
| Current assets | $m | [4,080](/filings/0000895419-23-000135.md) | [3,446](/filings/0000895419-24-000012.md) | [3,331](/filings/0000895419-24-000038.md) | [3,000](/filings/0000895419-25-000110.md) | [2,458](/filings/0000895419-24-000093.md) | [2,227](/filings/0000895419-25-000018.md) | [2,870](/filings/0000895419-25-000071.md) | [2,542](/filings/0000895419-26-000054.md) | [2,315](/filings/0000895419-25-000132.md) | [1,933](/filings/0000895419-26-000016.md) | [1,709](/filings/0000895419-26-000030.md) | [1,589](/filings/0000895419-26-000054.md) |
| Total assets | $m | [7,313](/filings/0000895419-23-000135.md) | [7,290](/filings/0000895419-24-000012.md) | [7,696](/filings/0000895419-24-000038.md) | [7,985](/filings/0000895419-25-000110.md) | [7,858](/filings/0000895419-24-000093.md) | [7,741](/filings/0000895419-25-000018.md) | [7,574](/filings/0000895419-25-000071.md) | [6,854](/filings/0000895419-26-000054.md) | [6,551](/filings/0000895419-25-000132.md) | [3,445](/filings/0000895419-26-000016.md) | [3,147](/filings/0000895419-26-000030.md) | [3,005](/filings/0000895419-26-000054.md) |
| Current liabilities | $m | [749](/filings/0000895419-23-000135.md) | [671](/filings/0000895419-24-000012.md) | [727](/filings/0000895419-24-000038.md) | [665](/filings/0000895419-25-000110.md) | [783](/filings/0000895419-24-000093.md) | [707](/filings/0000895419-25-000018.md) | [619](/filings/0000895419-25-000071.md) | [7,090](/filings/0000895419-26-000054.md) | [300](/filings/0000895419-25-000132.md) | [297](/filings/0000895419-26-000016.md) | [243](/filings/0000895419-26-000030.md) | [232](/filings/0000895419-26-000054.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7,302](/filings/0000895419-26-000054.md) | [7,632](/filings/0000895419-25-000132.md) | [2,818](/filings/0000895419-26-000016.md) | [2,126](/filings/0000895419-26-000030.md) | [2,075](/filings/0000895419-26-000054.md) |
| Long-term debt | $m | not reported | not reported | not reported | [6,161](/filings/0000895419-25-000110.md) | [6,170](/filings/0000895419-24-000093.md) | [6,424](/filings/0000895419-25-000018.md) | [6,512](/filings/0000895419-25-000071.md) | [6,538](/filings/0000895419-26-000054.md) | [0.0](/filings/0000895419-25-000132.md) | [1,964](/filings/0000895419-26-000016.md) | [1,721](/filings/0000895419-26-000030.md) | [1,688](/filings/0000895419-26-000054.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0000895419-25-000110.md) | not reported | not reported | not reported | [6,538](/filings/0000895419-26-000054.md) | [0.0](/filings/0000895419-25-000132.md) | [0.0](/filings/0000895419-26-000016.md) | [0.0](/filings/0000895419-26-000030.md) | [0.0](/filings/0000895419-26-000054.md) |
| Shareholders' equity | $m | [1,246](/filings/0000895419-25-000071.md) | [1,150](/filings/0000895419-25-000071.md) | [1,023](/filings/0000895419-25-000071.md) | [882](/filings/0000895419-26-000054.md) | [629](/filings/0000895419-26-000030.md) | [373](/filings/0000895419-26-000030.md) | [213](/filings/0000895419-26-000030.md) | [(447)](/filings/0000895419-26-000054.md) | [(1,080)](/filings/0000895419-26-000030.md) | [627](/filings/0000895419-26-000030.md) | [1,022](/filings/0000895419-26-000030.md) | [930](/filings/0000895419-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q4 FY2025 (2025-06-29) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(147)](/filings/0000895419-24-000093.md) | [(203) d](/filings/0000895419-25-000018.md) | [(136) d](/filings/0000895419-25-000071.md) | [(240) d](/filings/0000895419-26-000054.md) | [(132)](/filings/0000895419-25-000132.md) | [(195) d](/filings/0000895419-26-000016.md) | [(142) d](/filings/0000895419-26-000030.md) | [(243) d](/filings/0000895419-26-000054.md) | [5.7](/filings/0000895419-25-000132.md) | [(42.6)](/filings/0000895419-26-000016.md) | [(83.8) d](/filings/0000895419-26-000030.md) | [(54.4) d](/filings/0000895419-26-000054.md) |
| Capital expenditure | $m | [442](/filings/0000895419-24-000093.md) | [610 d](/filings/0000895419-25-000018.md) | [578 d](/filings/0000895419-25-000071.md) | [644 d](/filings/0000895419-26-000054.md) | [437](/filings/0000895419-25-000132.md) | [402 d](/filings/0000895419-26-000016.md) | [221 d](/filings/0000895419-26-000030.md) | [212 d](/filings/0000895419-26-000054.md) | [104](/filings/0000895419-25-000132.md) | [30.0](/filings/0000895419-26-000016.md) | [37.8 d](/filings/0000895419-26-000030.md) | [5.1 d](/filings/0000895419-26-000054.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-25) | Q2 FY2023 (2022-12-25) | Q3 FY2023 (2023-03-26) | Q1 FY2024 (2023-09-24) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-29) | Q2 FY2025 (2024-12-29) | Q3 FY2025 (2025-03-30) | Q1 FY2026 (2025-09-28) | Q2 FY2026 (2025-12-28) | Q3 FY2026 (2026-03-29) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [124](/filings/0000895419-23-000135.md) | [124](/filings/0000895419-24-000012.md) | [124](/filings/0000895419-24-000038.md) | [125](/filings/0000895419-24-000093.md) | [126](/filings/0000895419-25-000018.md) | [126](/filings/0000895419-25-000071.md) | [127](/filings/0000895419-25-000132.md) | [129](/filings/0000895419-26-000016.md) | [154](/filings/0000895419-26-000030.md) | [156](/filings/0000895419-25-000132.md) | [26.1](/filings/0000895419-26-000016.md) | [39.3](/filings/0000895419-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,995,396 at 2026-08-13, from the cover of the [10-K filed 2026-08-20](/filings/0000895419-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.